A61K 31 - Medicinal preparations containing organic active ingredients

Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
11/2004
11/18/2004	CA2524034A1 Uses of ion channel modulating compounds
11/18/2004	CA2524025A1 A pharmaceutical composition for the treatment of obesity or to facilitate or promote weight loss
11/18/2004	CA2524019A1 Positive modulators of nicotinic acetylcholine receptors
11/18/2004	CA2524009A1 Use of effectors of glutaminyl and glutamate cyclases
11/18/2004	CA2523922A1 Azaindole compounds as kinase inhibitors
11/18/2004	CA2523870A1 Claudins' underexpression as markers of tumor metastasis
11/18/2004	CA2523714A1 Substituted carboxylic acids
11/18/2004	CA2523709A1 Abuse-resistant transdermal dosage form
11/18/2004	CA2523425A1 Abuse-resistant transdermal dosage form
11/18/2004	CA2523242A1 Ginkgo biloba extract as a treatment for therapeutic induced neurotoxicity
11/18/2004	CA2523235A1 3-(1-naphthyl)-2-cyanopropanoic acid derivatives as estrogen receptor ligands
11/18/2004	CA2523072A1 Pyrrolo (1,2-b) pyridazine compounds and their use as crf-1 receptor antagonists
11/18/2004	CA2522573A1 Process for the preparation of famciclovir
11/18/2004	CA2522529A1 Tamper-resistant transdermal dosage form comprising an active agent component and an adverse agent component at the distal site of the active agent layer
11/18/2004	CA2521928A1 Freeze-dried preparation containing methylcobalamin and process for producing the same
11/18/2004	CA2521700A1 Piperidinyl- and piperazinyl-alkylcarbamate derivatives, preparation and therapeutic application thereof
11/18/2004	CA2518506A1 Nitrosated and nitrosylated compounds, compositions and methods of use
11/18/2004	CA2504493A1 Method of preventing infections from bioterrorism agents with immunostimulatory cpg oligonucleotides
11/18/2004	CA2504268A1 Nanoparticulate bioactive agents
11/17/2004	EP1477563A2 Cloning genes from streptomyces cyaneogriseus subsp.noncyanogenus for biosynthesis of antibiotics and methods of use
11/17/2004	EP1477494A1 Subunit respiratory syncytial virus vaccine preparation
11/17/2004	EP1477486A2 Imides as inhibitors of TNF alpha
11/17/2004	EP1477482A1 Novel phenylalanine derivative
11/17/2004	EP1477479A1 Process for the preparation of the D-(-)-tartrate salt of 1-(4-hydroxyphenyl)-2-(4-hydroxy-4-phenylpiperidin-1-YL)-1-propanol
11/17/2004	EP1477478A2 2-oxo-1-pyrrolidine derivatives, process for preparing them and their uses.
11/17/2004	EP1477187A1 Formulation for controlled release of drugs by combining hydrophilic and hydrophobic agents
11/17/2004	EP1477186A1 Antipruritics
11/17/2004	EP1477185A2 Pneumococcal genes, portions thereof, expression products therefrom and uses of such genes, portions and products
11/17/2004	EP1477182A1 Novel analgesics
11/17/2004	EP1477180A1 Inhibitors of proteasomal activity for stimulating bone and hair growth
11/17/2004	EP1477178A2 Health supplements containing phyto-oestrogens, analogues or metabolites thereof
11/17/2004	EP1477177A1 Process for producing hydrophobic glycyrrhiza extract with high qualities
11/17/2004	EP1477175A1 Fused pyridazine derivative compounds and drugs containing the compounds as the active ingredient
11/17/2004	EP1477173A1 Sugar phosphates and their use for improving the intestinal function
11/17/2004	EP1477172A1 Treatment of shipping fever
11/17/2004	EP1477171A1 Intestinal mineral absorption capacity improver
11/17/2004	EP1477170A1 Antipruritics
11/17/2004	EP1477169A1 Reactions of polymorphs of N-methyl-N-(3-(3-(2-thienylcarbonyl)-pyrazol-(1,5-alpha)-pyrimidin-7-yl)phenyl)acetamide
11/17/2004	EP1477168A1 Use of cabergoline in the treatment of restless leg syndrome
11/17/2004	EP1477166A1 The use of riluzol combined with excipients and additives for the treatment of disorders characterised by hyperproliferation of keratinocytes, in particular neurodermitis and psoriasis
11/17/2004	EP1477165A2 Blocking induction of tetrahydrobiopterin to block induction of nitric oxide synthesis
11/17/2004	EP1477164A1 Percutaneous absorption type plaster
11/17/2004	EP1477163A1 New film coating
11/17/2004	EP1477162A1 Controlled-release formulations coated with aqueous dispersions of ethylcellulose
11/17/2004	EP1477161A1 Pharmaceutical solid preparation containing a poorly soluble drug and production process thereof
11/17/2004	EP1476581A2 Recombinant bovine immunodeficiency virus based gene transfer system
11/17/2004	EP1476580A2 Multiple virus replicon culture systems
11/17/2004	EP1476574A2 RNA INTERFERENCE MEDIATED INHIBITION OF TYPE 1 INSULIN-LIKE GROWTH FACTOR RECEPTOR (IGF-1R) GENE EXPRESSION USING SHORT INTERFERING NUCLEIC ACID (siNA)
11/17/2004	EP1476564A1 Cooperative oligonucleotides
11/17/2004	EP1476553A2 Gene for peripheral arterial occlusive disease
11/17/2004	EP1476543A1 Viral variants with altered susceptibility to nucleoside analogs and uses thereof
11/17/2004	EP1476539A2 Streptomyces avermitilis gene directing the ratio of b2:b1 avermectins
11/17/2004	EP1476473A1 Novel natural cyclodextrin complexes
11/17/2004	EP1476471A1 Nutraceuticals for the treatment, protection and restoration of connective tissues
11/17/2004	EP1476458A2 Rna interference mediated inhibition of platelet derived growth factor (pdgf) and platelet derived growth factor receptor (pdgfr) gene expression using short interfering nucleic acid (sina)
11/17/2004	EP1476456A2 Compositions and methods for surrogate antibody modulation of an immune response and transport
11/17/2004	EP1476455A1 PARTIAL AND FULL AGONISTS OF A sb 1 /sb ADENOSINE RECEPTORS
11/17/2004	EP1476454A1 Binding epitopes for helicobacter pylori and use thereof
11/17/2004	EP1476449A1 Fused bicyclic-n-bridged-heteroaromatic carboxamides for the treatment of disease
11/17/2004	EP1476448A2 Azabicyclic compounds for the treatment of disease
11/17/2004	EP1476445A1 Tricyclic n-acyl compounds
11/17/2004	EP1476444A1 Heterocyclic compounds possessing affinity at 5ht1-type receptors and use thereof in therapy
11/17/2004	EP1476442A2 Lansoprazole polymorphs and processes for preparation thereof
11/17/2004	EP1476438A1 Oxa- and thiadiazoles and their use as metalloproteinase inhibitors
11/17/2004	EP1476435A1 Novel pyridin- and pyrimidin-derivatives
11/17/2004	EP1476434A2 Pyridazine derivatives, use of the same as medicaments, pharmaceutical compositions and method for producing the same
11/17/2004	EP1476433A1 Novel tricycloimidazoline derivatives, method for production and use thereof as medicaments
11/17/2004	EP1476432A1 Therapeutic substituted indazole derivatives
11/17/2004	EP1476431A1 Tricyclic pyrazole derivatives for the treatment of inflammation
11/17/2004	EP1476429A1 Novel pyridine- and quinoline-derivatives
11/17/2004	EP1476428A1 Pyridyl sulfone derivatives as 5-ht6 receptor ligands
11/17/2004	EP1476426A2 Hydroxylated indirubin derivatives
11/17/2004	EP1476425A2 Heterocyclic arylsulfonamidobenzylic compounds
11/17/2004	EP1476423A2 Arylsulfonamidobenzylic compounds
11/17/2004	EP1476421A2 Novel amino acid derivatives, method for production thereof and pharmaceutical compositions comprising said derivative
11/17/2004	EP1476419A2 N-biphenylmethyl aminocycloalkanecarboxamide derivatives
11/17/2004	EP1476199A2 Inhibition of lung metastases by aerosol delivery of p53 gene and anti-cancer compounds
11/17/2004	EP1476196A1 Oral solid solution formulation of a poorly water-soluble active substance
11/17/2004	EP1476195A2 Enhancement of the action of central and peripheral nervous system agents
11/17/2004	EP1476194A2 Compositions and methods for preservation of food
11/17/2004	EP1476193A1 A weight management system for obese animals
11/17/2004	EP1476192A1 Methods and compositions for treating hyperproliferative conditions
11/17/2004	EP1476187A2 Methods of extending corneal graft survival
11/17/2004	EP1476186A1 Use of an inhibitor or antagonist against tissue factor
11/17/2004	EP1476185A2 Antibodies to cd40
11/17/2004	EP1476181A2 Polyalkylene polymer compounds and uses thereof
11/17/2004	EP1476174A2 Pharmaceutical composition having prophylactic effects on lamivudine-related disease relapse and drug resistance and methods of using the same
11/17/2004	EP1476172A1 Use of a biotechnological honey substitute in a cosmetic or dermatological composition
11/17/2004	EP1476171A2 Transportation of nucleic acid substances
11/17/2004	EP1476169A1 Methods of inhibiting orthopoxvirus replication with nucleoside compounds
11/17/2004	EP1476168A2 Use of co-releasing compounds for the manufacture of a medicament for the treatment of inflammatory diseases
11/17/2004	EP1476167A1 Use of acylaminoalkenylene-amide derivatives in functional motility disorders of the viscera
11/17/2004	EP1476166A1 Use of low molecular weight compounds for preparing a medicament useful in treating mutant p53 mediated diseases
11/17/2004	EP1476165A1 Substituted pyrimidinones and pyrimidinthiones
11/17/2004	EP1476163A2 Method of treating hiv infection by preventing interaction of cd4 and gp120
11/17/2004	EP1476162A1 Controlled synthesis of ziprasidone and compositions thereof
11/17/2004	EP1476161A1 Piperidine and piperazine derivatives possessing affinity at 5ht-1 type receptors
11/17/2004	EP1476160A1 Pharmaceutical combination of artesunate and mefloquine for therapy of malaria
11/17/2004	EP1476159A2 Compositions and formulations of 9- nitrocamptothecin polymorphs and methods of use thereof
11/17/2004	EP1476158A1 Nicotinamide derivatives useful as pde4 inhibitors

1 ... 4889 4890 4891 4892 4893 4894 4895 4896 4897 4898 4899 4900 4901 4902 4903 4904 4905 4906 4907 4908 4909 ... 7860